pubmed-article:10416612 | rdf:type | pubmed:Citation | lld:pubmed |
pubmed-article:10416612 | lifeskim:mentions | umls-concept:C0086418 | lld:lifeskim |
pubmed-article:10416612 | lifeskim:mentions | umls-concept:C0007137 | lld:lifeskim |
pubmed-article:10416612 | lifeskim:mentions | umls-concept:C0460004 | lld:lifeskim |
pubmed-article:10416612 | lifeskim:mentions | umls-concept:C0521447 | lld:lifeskim |
pubmed-article:10416612 | lifeskim:mentions | umls-concept:C0079189 | lld:lifeskim |
pubmed-article:10416612 | lifeskim:mentions | umls-concept:C0038952 | lld:lifeskim |
pubmed-article:10416612 | lifeskim:mentions | umls-concept:C0598934 | lld:lifeskim |
pubmed-article:10416612 | lifeskim:mentions | umls-concept:C0017262 | lld:lifeskim |
pubmed-article:10416612 | lifeskim:mentions | umls-concept:C1512032 | lld:lifeskim |
pubmed-article:10416612 | lifeskim:mentions | umls-concept:C1515655 | lld:lifeskim |
pubmed-article:10416612 | lifeskim:mentions | umls-concept:C2911684 | lld:lifeskim |
pubmed-article:10416612 | lifeskim:mentions | umls-concept:C0185117 | lld:lifeskim |
pubmed-article:10416612 | pubmed:issue | 14 | lld:pubmed |
pubmed-article:10416612 | pubmed:dateCreated | 1999-8-12 | lld:pubmed |
pubmed-article:10416612 | pubmed:abstractText | We demonstrated recently that constitutive expression of proinflammatory cytokines interleukin (IL)-1alpha, IL-6, IL-8, and granulocyte-macrophage colony-stimulating factor in head and neck squamous cell carcinoma is correlated with activation of transcription factor nuclear factor (NF)-kappaB/Rel A (p50/p65), which binds the promoter region within each of the genes encoding this repertoire of cytokines. NF-kappaB can be activated after signal-dependent phosphorylation and degradation of inhibitor-kappaBalpha and has been reported to promote cell survival and growth. In the present study, we expressed a phosphorylation site mutant of inhibitor-kappaBalpha (IkappaBalphaM) in head and neck squamous cell carcinoma lines UM-SCC-9, -11B, and -38 to determine the effect of inhibition of NF-kappaB on cytokine expression, cell survival in vitro, and growth in vivo. After transfection with IKBalphaM, only a few UM-SCC-9 clones were obtained that stably expressed the mutant IkappaB, suggesting that expression of a mutant IkappaBalpha may affect survival of the transfected UM-SCC cell lines. After cotransfection of IkappaBalphaM with a Lac-Z reporter, we found that the number of surviving beta-galactosidase-positive cells in the three cell lines was reduced by 70-90% when compared with controls transfected with vector lacking the insert. In UM-SCC-9 cells that stably expressed IkappaBalphaM, inhibition of constitutive and tumor necrosis factor-a induced NF-kappaB activation, and production of all four cytokines was observed. Although UM-SCC-9 IkappaBalphaM-transfected cells proliferated at the same rate as vector-transfected cells in vitro, a significant reduction in growth of tumor xenografts was observed in SCID mice in vivo. The decreased growth of UM-SCC-9 IkappaBalphaM-transfected tumor cells accompanied decreased immunohistochemical detection of the activated form of NF-kappaB in situ. These results provide evidence that NF-KB and IkappaBalpha play an important role in survival, constitutive and inducible expression of proinflammatory cytokines, and growth of squamous cell carcinoma. NF-kappaB could serve as a potential target for therapeutic intervention against cytokine and other immediate-early gene responses that contribute to the survival, growth, and pathogenesis of these cancers. | lld:pubmed |
pubmed-article:10416612 | pubmed:grant | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:10416612 | pubmed:language | eng | lld:pubmed |
pubmed-article:10416612 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:10416612 | pubmed:citationSubset | IM | lld:pubmed |
pubmed-article:10416612 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:10416612 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:10416612 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:10416612 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:10416612 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:10416612 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:10416612 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:10416612 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:10416612 | pubmed:status | MEDLINE | lld:pubmed |
pubmed-article:10416612 | pubmed:month | Jul | lld:pubmed |
pubmed-article:10416612 | pubmed:issn | 0008-5472 | lld:pubmed |
pubmed-article:10416612 | pubmed:author | pubmed-author:ChefRR | lld:pubmed |
pubmed-article:10416612 | pubmed:author | pubmed-author:BrownKK | lld:pubmed |
pubmed-article:10416612 | pubmed:author | pubmed-author:SiebenlistUU | lld:pubmed |
pubmed-article:10416612 | pubmed:author | pubmed-author:DoneAA | lld:pubmed |
pubmed-article:10416612 | pubmed:author | pubmed-author:VEGAFF | lld:pubmed |
pubmed-article:10416612 | pubmed:author | pubmed-author:Van WaesCC | lld:pubmed |
pubmed-article:10416612 | pubmed:author | pubmed-author:OndreyF GFG | lld:pubmed |
pubmed-article:10416612 | pubmed:author | pubmed-author:DuffeyD CDC | lld:pubmed |
pubmed-article:10416612 | pubmed:issnType | Print | lld:pubmed |
pubmed-article:10416612 | pubmed:day | 15 | lld:pubmed |
pubmed-article:10416612 | pubmed:volume | 59 | lld:pubmed |
pubmed-article:10416612 | pubmed:owner | NLM | lld:pubmed |
pubmed-article:10416612 | pubmed:authorsComplete | Y | lld:pubmed |
pubmed-article:10416612 | pubmed:pagination | 3468-74 | lld:pubmed |
pubmed-article:10416612 | pubmed:dateRevised | 2008-11-21 | lld:pubmed |
pubmed-article:10416612 | pubmed:meshHeading | pubmed-meshheading:10416612... | lld:pubmed |
pubmed-article:10416612 | pubmed:meshHeading | pubmed-meshheading:10416612... | lld:pubmed |
pubmed-article:10416612 | pubmed:meshHeading | pubmed-meshheading:10416612... | lld:pubmed |
pubmed-article:10416612 | pubmed:meshHeading | pubmed-meshheading:10416612... | lld:pubmed |
pubmed-article:10416612 | pubmed:meshHeading | pubmed-meshheading:10416612... | lld:pubmed |
pubmed-article:10416612 | pubmed:meshHeading | pubmed-meshheading:10416612... | lld:pubmed |
pubmed-article:10416612 | pubmed:meshHeading | pubmed-meshheading:10416612... | lld:pubmed |
pubmed-article:10416612 | pubmed:meshHeading | pubmed-meshheading:10416612... | lld:pubmed |
pubmed-article:10416612 | pubmed:meshHeading | pubmed-meshheading:10416612... | lld:pubmed |
pubmed-article:10416612 | pubmed:meshHeading | pubmed-meshheading:10416612... | lld:pubmed |
pubmed-article:10416612 | pubmed:meshHeading | pubmed-meshheading:10416612... | lld:pubmed |
pubmed-article:10416612 | pubmed:meshHeading | pubmed-meshheading:10416612... | lld:pubmed |
pubmed-article:10416612 | pubmed:meshHeading | pubmed-meshheading:10416612... | lld:pubmed |
pubmed-article:10416612 | pubmed:meshHeading | pubmed-meshheading:10416612... | lld:pubmed |
pubmed-article:10416612 | pubmed:meshHeading | pubmed-meshheading:10416612... | lld:pubmed |
pubmed-article:10416612 | pubmed:meshHeading | pubmed-meshheading:10416612... | lld:pubmed |
pubmed-article:10416612 | pubmed:meshHeading | pubmed-meshheading:10416612... | lld:pubmed |
pubmed-article:10416612 | pubmed:meshHeading | pubmed-meshheading:10416612... | lld:pubmed |
pubmed-article:10416612 | pubmed:meshHeading | pubmed-meshheading:10416612... | lld:pubmed |
pubmed-article:10416612 | pubmed:meshHeading | pubmed-meshheading:10416612... | lld:pubmed |
pubmed-article:10416612 | pubmed:meshHeading | pubmed-meshheading:10416612... | lld:pubmed |
pubmed-article:10416612 | pubmed:meshHeading | pubmed-meshheading:10416612... | lld:pubmed |
pubmed-article:10416612 | pubmed:meshHeading | pubmed-meshheading:10416612... | lld:pubmed |
pubmed-article:10416612 | pubmed:meshHeading | pubmed-meshheading:10416612... | lld:pubmed |
pubmed-article:10416612 | pubmed:meshHeading | pubmed-meshheading:10416612... | lld:pubmed |
pubmed-article:10416612 | pubmed:year | 1999 | lld:pubmed |
pubmed-article:10416612 | pubmed:articleTitle | Expression of a dominant-negative mutant inhibitor-kappaBalpha of nuclear factor-kappaB in human head and neck squamous cell carcinoma inhibits survival, proinflammatory cytokine expression, and tumor growth in vivo. | lld:pubmed |
pubmed-article:10416612 | pubmed:affiliation | Tumor Biology Section, Head and Neck Surgery Branch, National Institute on Deafness and Other Communication Disorders, NIH, Bethesda, Maryland 20892, USA. | lld:pubmed |
pubmed-article:10416612 | pubmed:publicationType | Journal Article | lld:pubmed |
pubmed-article:10416612 | pubmed:publicationType | Research Support, U.S. Gov't, P.H.S. | lld:pubmed |
http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:10416612 | lld:pubmed |
http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:10416612 | lld:pubmed |
http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:10416612 | lld:pubmed |
http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:10416612 | lld:pubmed |
http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:10416612 | lld:pubmed |
http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:10416612 | lld:pubmed |
http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:10416612 | lld:pubmed |
http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:10416612 | lld:pubmed |
http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:10416612 | lld:pubmed |
http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:10416612 | lld:pubmed |
http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:10416612 | lld:pubmed |
http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:10416612 | lld:pubmed |
http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:10416612 | lld:pubmed |
http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:10416612 | lld:pubmed |
http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:10416612 | lld:pubmed |
http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:10416612 | lld:pubmed |
http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:10416612 | lld:pubmed |
http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:10416612 | lld:pubmed |
http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:10416612 | lld:pubmed |
http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:10416612 | lld:pubmed |
http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:10416612 | lld:pubmed |
http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:10416612 | lld:pubmed |
http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:10416612 | lld:pubmed |
http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:10416612 | lld:pubmed |
http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:10416612 | lld:pubmed |
http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:10416612 | lld:pubmed |
http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:10416612 | lld:pubmed |
http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:10416612 | lld:pubmed |
http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:10416612 | lld:pubmed |
http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:10416612 | lld:pubmed |
http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:10416612 | lld:pubmed |